We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Kenexa Corp. | NYSE:KNXA | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 45.96 | 0.00 | 01:00:00 |
FORM 4
[
X
]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
Restivo James P |
2. Issuer Name
and
Ticker or Trading Symbol
KENEXA CORP [ KNXA ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) CHIEF TECHNOLOGY OFFICER |
650 E. SWEDESFORD ROAD, SECOND FLOOR |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
WAYNE, PA 19087 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
COMMON STOCK | 12/3/2012 | D | 23917 | D | (1) | 26750 | D | |||
COMMON STOCK | 12/3/2012 | D | 26750 | D | $46.00 (2) | 0 | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
STOCK OPTION (RIGHT TO BUY) | $18.66 | 12/3/2012 | D | 25000 | (3) | 1/2/2013 | COMMON STOCK | 25000 | $27.34 (4) | 0 | D | ||||
STOCK OPTION (RIGHT TO BUY) | $5.11 | 12/3/2012 | D | 20000 | (3) | 11/25/2018 | COMMON STOCK | 20000 | $40.89 (5) | 0 | D | ||||
STOCK OPTION (RIGHT TO BUY) | $4.74 | 12/3/2012 | D | 40000 | (6) | 2/19/2019 | COMMON STOCK | 40000 | (6) | 0 | D | ||||
STOCK OPTION (RIGHT TO BUY) | $10.50 | 12/3/2012 | D | 40000 | (7) | 2/17/2020 | COMMON STOCK | 40000 | (7) | 0 | D | ||||
STOCK OPTION (RIGHT TO BUY) | $25.00 | 12/3/2012 | D | 1000 | (8) | 2/16/2021 | COMMON STOCK | 1000 | (8) | 0 | D | ||||
STOCK OPTION (RIGHT TO BUY) | $28.48 | 12/3/2012 | D | 20000 | (9) | 2/27/2022 | COMMON STOCK | 20000 | (9) | 0 | D |
Explanation of Responses: | |
( 1) | In connection with a merger agreement between the Issuer and International Business Machines Corporation ("IBM"), this amount represents unvested Kenexa restricted stock units ("RSUs") that were cancelled in exchange for restricted stock units with respect to shares of IBM common stock ("IBM RSUs") using an exchange ratio of 0.240805 IBM RSUs for each Kenexa RSU. |
( 2) | Disposed of pursuant to the merger agreement in exchange for a cash payment of $46.00 per share on the effective date of the merger. |
( 3) | The stock option is fully vested and exercisable. |
( 4) | Pursuant to the terms of the merger agreement, this option was cancelled in exchange for a cash payment of $683,500, representing the aggregate difference between the merger consideration of $46.00 per share and the exercise price of the option on the effictive date of the merger. |
( 5) | Pursuant to the terms of the merger agreement, this option was cancelled in exchange for a cash payment of $817,800, representing the aggregate difference between the merger consideration of $46.00 per share and the exercise price of the option on the effictive date of the merger. |
( 6) | This option was granted on February 19, 2009 and was vested as to 30,000 shares on the effective date of the merger. Pursuant to the terms of the merger agreement this option was, (i) with respect to 30,000 vested and unexercised shares, cancelled in exchange for a cash payment of $1,237,800, representing the aggregate difference between the merger consideration of $46.00 per share the exercise price of the option; and, (ii) with respect to 10,000 unvested shares, was converted into an option to acquire shares of IBM common stock at an exercise price of $19.61/share, with the right to acquire each Issuer share converted into the right to acquire 0.2417 shares of IBM common stock. |
( 7) | This option was granted on February 17, 2010 and was vested as to 20,000 shares on the effective date of the merger. Pursuant to the terms of the merger agreement this option was, (i) with respect to 20,000 vested and unexercised shares, cancelled in exchange for a cash payment of $710,000, representing the aggregate difference between the merger consideration of $46.00 per share the exercise price of the option; and, (ii) with respect to 20,000 unvested shares, was converted into an option to acquire shares of IBM common stock at an exercise price of $43.44/share, with the right to acquire each Issuer share converted into the right to acquire 0.2417 shares of IBM common stock. |
( 8) | This option was granted on February 16, 2011 and was vested as to 250 shares on the effective date of the merger. Pursuant to the terms of the merger agreement this option was, (i) with respect to 250 vested and unexercised shares, cancelled in exchange for a cash payment of $5,250, representing the aggregate difference between the merger consideration of $46.00 per share the exercise price of the option; and, (ii) with respect to 750 unvested shares, was converted into an option to acquire shares of IBM common stock at an exercise price of $103.44/share, with the right to acquire each Issuer share converted into the right to acquire 0.2417 shares of IBM common stock. |
( 9) | This option was granted on February 27, 2012 and, pursuant to the terms of the merger agreement this option was, with respect to 20,000 unvested shares, was converted into an option to acquire shares of IBM common stock at an exercise price of $117.84/share, with the right to acquire each Issuer share converted into the right to acquire 0.2417 shares of IBM common stock. |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Restivo James P
650 E. SWEDESFORD ROAD SECOND FLOOR WAYNE, PA 19087 |
|
|
CHIEF TECHNOLOGY OFFICER |
|
Signatures
|
||
Donald F. Volk, as Attorney-In-Fact for James P. Restivo | 12/4/2012 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Kenexa Corp. Chart |
1 Month Kenexa Corp. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions